Spruce Biosciences (SPRB) News Today $0.07 0.00 (-3.61%) As of 06/13/2025 03:22 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SPRB Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Spruce Biosciences gets conditional approval to resume trading on Nasdaq Capital MarketJune 13 at 8:21 AM | msn.comSpruce Biosciences Announces Conditional Nasdaq Approval to Resume Trading on the Nasdaq Capital MarketJune 12 at 8:42 AM | finance.yahoo.comSpruce Biosciences’ Compliance Plan Accepted by NasdaqJune 12 at 8:34 AM | tipranks.comSpruce Biosciences, Inc. (NASDAQ:SPRB) Given Average Recommendation of "Hold" by AnalystsJune 5, 2025 | americanbankingnews.comSpruce Biosciences’ SWOT analysis: stock pivots amid clinical setbacksMay 7, 2025 | investing.comSpruce Biosciences Inc Ordinary SharesMay 6, 2025 | morningstar.comSpruce Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate UpdatesMay 6, 2025 | finance.yahoo.comSpruce Biosciences (SPRB) Receives a Hold from RBC CapitalApril 17, 2025 | markets.businessinsider.comSpruce Biosciences, Inc. (NASDAQ:SPRB) Q1 2023 Earnings Call TranscriptApril 17, 2025 | insidermonkey.comWith BioMarin deal, Spruce Biosciences hits reset on rare-disease drugApril 15, 2025 | bizjournals.comSpruce Biosciences, Inc. (SPRB) Corporate Update Conference Call (Transcript)April 15, 2025 | seekingalpha.comSpruce Biosciences reports delayed annual filingApril 3, 2025 | investing.comHold Rating for Spruce Biosciences Amid Clinical Setbacks and Strategic UncertaintiesDecember 16, 2024 | markets.businessinsider.comJMP Securities Downgrades Spruce Biosciences (SPRB)December 12, 2024 | msn.comSpruce Biosciences Downgraded to Hold Amid Unmet Clinical Trial Endpoints and Strategic ReevaluationDecember 11, 2024 | markets.businessinsider.comOppenheimer Downgrades Spruce Biosciences (SPRB)December 11, 2024 | msn.comSpruce Biosciences Announces Topline Results from CAHmelia-204 in Adult CAH and CAHptain-205 in Adult and Pediatric CAHDecember 11, 2024 | finance.yahoo.comSpruce Biosciences CAHmelia-204 study did not achieve primary efficacy endpointDecember 11, 2024 | markets.businessinsider.comJMP Securities downgrades Spruce Biosciences (SPRB) to a HoldDecember 11, 2024 | markets.businessinsider.comSpruce Biosciences downgraded to Market Perform from Outperform at JMPDecember 11, 2024 | msn.comSpruce Biosciences to wind down investment for genetic disorder drugDecember 10, 2024 | reuters.comCautious Optimism for Tildacerfont in CAH Trials: Potential Market Opportunities and Competitive Edge Over CrinecerfontDecember 6, 2024 | markets.businessinsider.comRBC Capital Sticks to Their Hold Rating for Spruce Biosciences (SPRB)November 13, 2024 | markets.businessinsider.comSpruce Biosciences Faces Nasdaq Delisting Threat: Can a Reverse Stock Split Save Its Market Presence?November 13, 2024 | markets.businessinsider.comSpruce Biosciences Reports Q3 2024 Earnings and UpdatesNovember 11, 2024 | tipranks.comSpruce Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate UpdatesNovember 11, 2024 | finanznachrichten.deSpruce Biosciences, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Shareholders To Reach OutNovember 1, 2024 | stockhouse.comSpruce Biosciences to Participate in the Guggenheim Securities Healthcare Innovation ConferenceOctober 28, 2024 | businesswire.comSpruce Biosciences (NASDAQ:SPRB) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comAnalysts Offer Insights on Healthcare Companies: Acrivon Therapeutics, Inc. (ACRV) and Spruce Biosciences (SPRB)September 12, 2024 | markets.businessinsider.comThe Schall Law Firm Is Looking Into Whether Spruce Biosciences, Inc. Committed Securities Fraud And The Firm Wants Affected Shareholders To Reach OutSeptember 10, 2024 | stockhouse.comSpruce Biosciences to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 3, 2024 | finance.yahoo.comThe Schall Law Firm Is Investigating Spruce Biosciences Inc For Potential Securities Law Violations And Investors Are Urged To Reach OutAugust 25, 2024 | stockhouse.comAn Securities Fraud Inquiry Has Been Opened Into Spruce Biosciences Inc And The Schall Law Firm Seeks Shareholder ParticipationAugust 24, 2024 | stockhouse.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Kronos Bio (KRON), Spruce Biosciences (SPRB) and scPharmaceuticals (SCPH)August 19, 2024 | markets.businessinsider.comBuy Rating Affirmed for Spruce Biosciences Amid Anticipated Positive Clinical Trial Outcomes and Strong Financial PositionAugust 14, 2024 | markets.businessinsider.comSpruce Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate UpdatesAugust 13, 2024 | finance.yahoo.comSPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q2 2024August 13, 2024 | investorplace.comOptimistic Outlook for Spruce Biosciences: Tildacerfont’s Market Potential Amidst Upcoming Trial DataJuly 26, 2024 | markets.businessinsider.comSpruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD)June 4, 2024 | businesswire.comSpruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024June 3, 2024 | businesswire.comSpruce Biosciences to Participate in the Jefferies Global Healthcare ConferenceMay 23, 2024 | finance.yahoo.comSpruce Biosciences to Participate in the Jefferies Global Healthcare ConferenceMay 23, 2024 | businesswire.comHold Rating on Spruce Biosciences Amid Clinical Trial Uncertainties and Rising CompetitionMay 16, 2024 | markets.businessinsider.comSpruce Biosciences, Inc. (SPRB)May 16, 2024 | finance.yahoo.comBuy Rating Affirmed for Spruce Biosciences Amid Upcoming Trial Data and Strong Financial PositionMay 15, 2024 | markets.businessinsider.comSPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q1 2024May 13, 2024 | msn.comSpruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesMay 13, 2024 | businesswire.comSpruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual MeetingApril 30, 2024 | finance.yahoo.comSpruce Biosciences Inc (SPRB)April 26, 2024 | investing.com Get Spruce Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SPRB and its competitors with MarketBeat's FREE daily newsletter. Email Address SPRB Media Mentions By Week SPRB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SPRB News Sentiment▼0.360.88▲Average Medical News Sentiment SPRB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SPRB Articles This Week▼40▲SPRB Articles Average Week Get Spruce Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SPRB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NLS Pharmaceutics News Today Kiora Pharmaceuticals News Today AEON Biopharma News Today Brainstorm Cell Therapeutics News Today Carisma Therapeutics News Today Moleculin Biotech News Today Dogwood Therapeutics News Today Lakeshore Biopharma News Today Traws Pharma News Today Biomerica News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SPRB) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s worst nightmareThe President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spruce Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spruce Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SPRB Stock Free SPRB Stock Alerts